2831 |
ESORAL 20 |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USP 22.275 MG EQ.TO ESOMEPRAZOLE 20 MG |
CAPSULE |
ALU-ALU BLISTER |
TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, ERADICATION OF HELICOBACTER PYLORI IN COMBINATION WITH APPROPRIATE ANTIBIOTICS, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH H.PYLORI ASSOCIATED ULCER. |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4760/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
2832 |
ESORAL 40 |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USP 44.550 MG EQ.TO ESOMEPRAZOLE 40 MG |
CAPSULE |
ALU-ALU BLISTER |
TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE, ERADICATION OF HELICOBACTER PYLORI IN COMBINATION WITH APPROPRIATE ANTIBIOTICS, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH H.PYLORI ASSOCIATED ULCER. |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
06 I 4761/19 |
07-JUL-2025 |
06-JUL-2030 |
View |
2833 |
EZYCID |
SIMETHICONE BP 50 MG, MAGNESIUM HYDROXIDE BP 250 MG, DRIED ALUMINIUM HYDROXIDE BP 250 MG, MAGNESIUM ALUMINIUM SILICATE HYDRATE 50 MG |
TABLET |
ALU-PVC BLISTER |
GASTRIC DISTRESS RESULTING FROM RETENTION OF GAS AND HYPERACIDITY SUCH AS MAY OCCUR IN FUNCTIONAL DYSPEPSIA, THE LATTER MAY RESULT FROM DIETARY INDISCRETION, AIR SWALLOWING, EXCESSIVE SMOKING, CONSTIPATION OR ALTERED GASTRIC MOTOR ACTIVITY. GASTRIC HYPERACIDITY, GASTRITIS, HEART BURN OF PREGNACY, OESOPHAGITIS |
NULL |
VIMPEX (LAO) CO.,LTD |
S KANT HEALTHCARE LTD |
INDIA |
CERTIFICATE RELEASED |
01 I 5686/24 |
06-FEB-2024 |
05-FEB-2027 |
View |
2834 |
FEBULIV 40 |
FEBUXOSTAT 40 MG |
FILM COATED TABLET |
ALU-ALU BLISTER, ALU-PVC BLISTER & BOTTLE |
TREATMENT OF CHRONIC HYPERURICAEMIA IN CONDITIONS WHERE URATE DEPOSITION HAS ALREADY OCCURED (INCLUDING A HISTORY, OR PRESENCE OF, TOPHUS AND/OR GOUTY ARTHRITIS). |
NULL |
VIMPEX (LAO) CO.,LTD |
RV LIFECIENCES LIMITED |
INDIA |
CERTIFICATE RELEASED |
09 I 5811/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
2835 |
FEBULIV 80 |
FEBUXOSTAT 80 MG |
FILM COATED TABLET |
ALU-ALU BLISTER, ALU-PVC BLISTER & BOTTLE |
TREATMENT OF CHRONIC HYPERURICAEMIA IN CONDITIONS WHERE URATE DEPOSITION HAS ALREADY OCCURED (INCLUDING A HISTORY, OR PRESENCE OF, TOPHUS AND/OR GOUTY ARTHRITIS). |
NULL |
VIMPEX (LAO) CO.,LTD |
RV LIFECIENCES LIMITED |
INDIA |
CERTIFICATE RELEASED |
09 I 5812/24 |
25-SEP-2024 |
24-SEP-2029 |
View |
2836 |
FECONTIN-Z |
FERROUS GLYCINE SULPHATE EQ.TO FERROUS IRON 100 MG, ZINC SULFATE MONOHYDRATE USP 61.8 MG, FOLIC ACID BP 0.5 MG |
FILM COATED TABLET |
ALU/PVC/PVDC STRIP |
FOR THE PROPHYLAXIS OF IRON, ZINC AND FOLIC ACID DEFICIENCY DURING PREGNANCY (SECOND AND THIRD TRIMESTER ) AND LACTATION |
NULL |
VIMPEX (LAO) CO.,LTD |
MODI-MUNDIPHARMA PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5772/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
2837 |
FLUNARIN 10 |
FLUNARIZINE DIHYDROCHLORIDE BP EQ.TO FLUNARIZINE 10 MG |
TABLET |
ALU-PVC BLISTER |
USED IN THE PROPHYLAXIS OF MIGRAINE, OCCLUSIVE PERIPHERAL VASCULAR DISEASE, VERTIGO OF CENTRAL AND PERIPHERAL ORIGIN, AND AS AN ADJUVANT IN THE THERAPY OF EPILEPSY |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5773/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
2838 |
FLUNARIN 5 |
FLUNARIZINE DIHYDROCHLORIDE BP EQ.TO FLUNARIZINE 5 MG |
TABLET |
ALU-PVC BLISTER |
USED IN THE PROPHYLAXIS OF MIGRAINE, OCCLUSIVE PERIPHERAL VASCULAR DISEASE, VERTIGO OF CENTRAL AND PERIPHERAL ORIGIN, AND AS AN ADJUVANT IN THE THERAPY OF EPILEPSY |
NULL |
VIMPEX (LAO) CO.,LTD |
FDC LIMITED |
INDIA |
CERTIFICATE RELEASED |
06 I 5774/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
2839 |
GASTID |
EACH 100 ML CONTAINS: MAGALDRATE GEL (21.5 %) USP 44.651 G , SIMETHICONE (30 % EMULSION ) USP 1.333 G |
SUSPENSION |
BOTTLE |
RELIEF OF SYMPTOMS OF DYSPEPSIA, HEARTBURN, ACID INDIGESTION, SOUR STOMACH, GASTROESOPHAGEAL REFLUX AND HIATAL HERNIA, ALSO PRESCRIBED IN HYPERACIDITY ASSOCIATED WITH PEPTIC ULCERS, GASTRITIS AND ESOPHAGITIS |
NULL |
VIMPEX (LAO) CO.,LTD |
ESKAYEF PHARMACEUTICALS LIMITED |
BANGLADESH |
CERTIFICATE RELEASED |
07 I 4526/18 |
07-JUL-2025 |
06-JUL-2030 |
View |
2840 |
GLIPITA 100 |
SITAGLIPTIN PHOSPHATE MONOHYDRATE BP 128.500 MG EQ.TO SITAGLIPTIN 100 MG |
TABLET |
ALU-ALU BLISTER |
AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN PATIENTS WITH TYPE II DIABETES MELLITUS |
NULL |
VIMPEX (LAO) CO.,LTD |
BEXIMCO PHARMACEUTICALS LTD |
BANGLADESH |
CERTIFICATE RELEASED |
10 I 4611/18 |
08-JAN-2024 |
07-JAN-2027 |
View |